Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04189445
Title Futibatinib in Patients With Specific FGFR Aberrations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

Advanced Solid Tumor

lymphoma

gastroesophageal junction adenocarcinoma

myeloid neoplasm

stomach cancer

Therapies

Futibatinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST